Summary of all the Indicators
Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
TG Therapeutics’s (NKB2) Moving Averages Convergence Divergence (MACD) indicator is 1.04, suggesting TG Therapeutics is a Sell.
TG Therapeutics’s (NKB2) 20-Day exponential moving average is 46.09, while TG Therapeutics’s (NKB2) share price is €46.9, making it a Buy.
TG Therapeutics’s (NKB2) 50-Day exponential moving average is 44.60, while TG Therapeutics’s (NKB2) share price is €46.9, making it a Buy.
TG Therapeutics (NKB2) Pivot Points
Classic
47.90
48.20
48.80
49.10
49.70
50.00
50.60
Fibonacci
48.20
48.54
48.76
49.10
49.44
49.66
50.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
TG Therapeutics (NKB2) Moving Averages
MA5
47.78Buy
48.05Buy
MA10
47.44Buy
47.13Buy
MA20
44.91Buy
46.09Buy
MA50
46.14Buy
44.60Buy
MA100
40.99Buy
41.28Buy
MA200
33.47Buy
35.96Buy
TG Therapeutics’s (NKB2) 10-Day exponential moving average is 47.13, while TG Therapeutics’s (NKB2) share price is €46.9, making it a Buy.
TG Therapeutics’s (NKB2) 100-Day exponential moving average is 41.28, while TG Therapeutics’s (NKB2) share price is €46.9, making it a Buy.
TG Therapeutics’s (NKB2) stock price is €46.9 and TG Therapeutics’s (NKB2) 50-day simple moving average is 46.14, creating a Buy signal.
TG Therapeutics’s (NKB2) stock price is €46.9 and TG Therapeutics’s (NKB2) 100-day simple moving average is 40.99, creating a Buy signal.
TG Therapeutics’s (NKB2) stock price is €46.9 and TG Therapeutics’s (NKB2) 200-day simple moving average is 33.47, creating a Buy signal.
TG Therapeutics (NKB2) Technical Indicators
RSI (14)
58.56
Neutral
STOCH (9,6)
89.22
Sell
STOCHRSI (14)
95.05
Sell
MACD (12,26)
1.04
Sell
ADX (14)
20.20
Neutral
Williams %R
-14.86
Sell
CCI (14)
91.45
Neutral
ATR (14)
1.20
-
Ultimate Oscillator
64.10
Neutral
ROC
15.83
Buy
TG Therapeutics’s (NKB2) Relative Strength Index (RSI) is 58.56, creating a Neutral signal.
TG Therapeutics’s (NKB2) Trend Strength Indicator (ADX) is 20.20, creating a Neutral signal.
TG Therapeutics’s (NKB2) Commodity Channel Index (CCI) is 91.45, creating a Neutral signal.
TG Therapeutics’s (NKB2) Price Rate of Change (ROC) is 15.83, creating a Buy signal.
FAQ
Is NKB2 a Buy, Hold, or Sell?
Based on NKB2’s technical indicators, NKB2 is a Buy.
What is NKB2’s RSI (14)?
NKB2’s RSI (14) is 58.56, which suggests NKB2 is a Neutral.
What is NKB2’s MACD?
NKB2’s MACD is 1.04, which suggests NKB2 is a Sell.
What is NKB2’s 5-day moving average?
NKB2’s 5-day moving average is 47.78, which suggests NKB2 is a Buy.
What is NKB2’s 20-day moving average?
NKB2 20-day moving average is 44.91, which suggests NKB2 is a Buy.
What is NKB2’s 50-day moving average?
NKB2’s 50-day moving average is 46.14, which suggests NKB2 is a Buy.
What is NKB2’s 200-day moving average?
NKB2’s 200-day moving average is 33.47, which suggests NKB2 is a Buy.
What is NKB2’s Williams % R (14)?
NKB2’s Williams % R (14) is -14.86, which suggests NKB2 is a Sell.
What is NKB2’s CCI (14)?
NKB2’s CCI (14) is 91.45, which suggests NKB2 is a Neutral.
What is the share price of TG Therapeutics?
TG Therapeutics's share price is N/A€.